7th Jan 2025 07:00
7 January 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services, announces that it was made aware on 6 January 2025 that, as part of a dividend reinvestment plan, Joanne Shaw, Non-executive Director, purchased 14 ordinary shares of £0.002 each ("Ordinary Shares") at a price of 840.25 pence per Ordinary Share on 29 November 2024. Following this transaction, she holds a total of 1,562 Ordinary Shares, representing approximately 0.002% of the current Issued Share Capital of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Joanne Shaw | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR (Non-Executive Director) | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.2 pence each
GB00B2863827
| ||||
b)
| Nature of the transaction
| On-market purchase | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction | ||||
e)
| Date of the transaction
| 29 November 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange - AIM (XLON) | ||||
Related Shares:
CVS Group